Despite Uptake Barriers, Real-World Biosimilar Data Demonstrate Safety, Efficacy, Cost-Effectiveness
AJMC,
Biosimilars were a recurring subject at The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Biosimilars were a recurring subject at The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
ABSTRACT Objectives: Biosimilars are highly similar to FDA-approved biologics, with no meaningful clinical difference between…
While there are many physicians who are very knowledgeable about biosimilars, a large number of them will require education…